Filing metadata

Accession number
0001415889-24-024378
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Oct 02, 2024
Reporting period
Oct 01, 2024
Description
Insider transaction

Explore SEC Filings Hub